Pulmonary Function Testing Systems Market

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Pulmonary Function Testing Systems Market contains market size and forecasts of Pulmonary Function Testing Systems in global, including the following market information:

Global Pulmonary Function Testing Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pulmonary Function Testing Systems Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Pulmonary Function Testing Systems companies in 2021 (%)

The global Pulmonary Function Testing Systems market was valued at 410.8 million in 2021 and is projected to reach US$ 541.2 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Portable PFT Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pulmonary Function Testing Systems include CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato and Ganshorn, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Pulmonary Function Testing Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pulmonary Function Testing Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pulmonary Function Testing Systems Market Segment Percentages, by Type, 2021 (%)

Portable PFT Systems

Complete PFT Systems

Global Pulmonary Function Testing Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pulmonary Function Testing Systems Market Segment Percentages, by Application, 2021 (%)

Hospitals

Physical Examination Center

Physician Groups

Others

Global Pulmonary Function Testing Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pulmonary Function Testing Systems Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pulmonary Function Testing Systems revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pulmonary Function Testing Systems revenues share in global market, 2021 (%)

Key companies Pulmonary Function Testing Systems sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Pulmonary Function Testing Systems sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CareFusion(BD)

Schiller

CHEST

COSMED

nSpire Health

NDD

MGC Diagnostics

Minato

Ganshorn

AESRI

Morgan Scientific

M&B

Sikeda

RSDQ